Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Genetic Signature to Predict the Development of Sarcomas

NCT03625791 is registered in ClinicalTrials.gov with Centre Georges Francois Leclerc as lead sponsor.

NCT NCT03625791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03625791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Genetic Signature to Predict the Development of Sarcomas
Lead sponsor
Centre Georges Francois Leclerc
Phase
Observational
Overall status
Completed
Start date
June 19, 2018
Completion date
June 19, 2022
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

genetic signature in development of sarcomas